|
KEY BIOMEDICAL SERVICES |
|
Copyright 2012 Key Biomedical Services |
|
A Pathology Outsourcing Service |
|
KEY BIOMEDICAL SERVICES |
|
Copyright 2012 Key Biomedical Services |
|
Pulmonary lymphoma identified by the presence of the CD45 marker (red). Residual normal lung tissue demonstrates positive staining for the Thyroid Transcription Factor-1 marker (brown).
The diagnosis of pulmonary lymphoma (versus adenocarcinoma) is established by the presence of CD45 on the malignant cells. |
|
Key Biomedical Services was established in 2004 to provide pathology services for researchers, clinicians, pharmaceutical companies, and medical device manufacturers. We specialize in the tissue-based test methods of immunohistochemistry and in situ hybridization. We provide a wide range of products and services for technology and business development, quality systems development, and regulatory compliance. Our laboratory can also assist you in product development. Our goal is to provide a cost-effective alternative to your in-house development. By outsourcing your pathology projects, you will not only save on internal costs, but you will also have access to the best expertise and technology available. |
|
To Contact Us: |
|
About Us |
|
Fluorescence in situ hybridization showing amplification of the Her2/neu gene in breast cancer |
|
A Pathology Outsourcing Service |
